For this reason, approaches to induce a partial decrease in circulating leptin and simultaneous increase in leptin sensitivity are being studied to replace other treatments for obesity with adverse effects. The gene discussed is LEP; the disease is obesity due to melanocortin 4 receptor deficiency.